SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-005029
Filing Date
2024-01-17
Accepted
2024-01-17 16:14:36
Documents
19
Period of Report
2024-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K celu-20240112.htm   iXBRL 8-K 70467
2 EX-10.1 celu-ex10_1.htm EX-10.1 342937
3 EX-10.2 celu-ex10_2.htm EX-10.2 95723
4 EX-10.3 celu-ex10_3.htm EX-10.3 309756
5 EX-10.4 celu-ex10_4.htm EX-10.4 98335
6 EX-10.5 celu-ex10_5.htm EX-10.5 312527
7 EX-10.6 celu-ex10_6.htm EX-10.6 96034
8 EX-10.7 celu-ex10_7.htm EX-10.7 106184
9 EX-10.8 celu-ex10_8.htm EX-10.8 310289
10 EX-10.9 celu-ex10_9.htm EX-10.9 105989
  Complete submission text file 0000950170-24-005029.txt   2262444

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT celu-20240112.xsd EX-101.SCH 49803
13 EXTRACTED XBRL INSTANCE DOCUMENT celu-20240112_htm.xml XML 6500
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 24538563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)